Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Matthew HowellPaul Lorigan

Abstract

Antibodies against immune checkpoints including CTLA-4, PD-1 and PD-L1 are increasingly being used in lung cancer. They are associated with novel, immune related toxicities not previously encountered with established treatments for lung cancer including colitis, hepatitis, rashes, neuropathies and other rarer immune mediated toxicities. Although generally these are low grade, there is a potential to be life threatening if not managed promptly. Early recognition of toxicity and institution of management algorithms are key to ensuring patient safety. We review the common toxicities and provide recommendations on their management.

References

Aug 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter AttiaSteven A Rosenberg
Nov 6, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stephanie G DowneySteven A Rosenberg
Nov 15, 2008·The Oncologist·Jedd D Wolchok, Yvonne Saenger
Jun 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·David R MinorMohammed Kashani-Sabet
Jul 10, 2009·The New England Journal of Medicine·Fouad FadelBertrand Knebelmann
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L CrinòUNKNOWN ESMO Guidelines Working Group
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G D'AddarioUNKNOWN ESMO Guidelines Working Group
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SørensenUNKNOWN ESMO Guidelines Working Group
Nov 16, 2010·Seminars in Oncology·Anna Maria Di GiacomoMichele Maio
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katarzyna D ChmielRichard Kefford
Jun 7, 2011·The New England Journal of Medicine·Caroline RobertJedd D Wolchok
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J LynchMartin Reck
May 23, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey S WeberAxel Hauschild
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
May 30, 2013·American Society of Clinical Oncology Educational Book·Laura Q M Chow
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jan 22, 2014·Nature Reviews. Clinical Oncology·Tara C Gangadhar, Robert H Vonderheide
Feb 18, 2014·Journal of Neuro-oncology·Paola QueiroloVanna Chiarion Sileni
Mar 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suzanne L TopalianF Stephen Hodi
Apr 3, 2014·Clinical Pharmacology and Therapeutics·R D Harvey
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Víctor M Castellano-MegíasFrancisco Colina-Ruizdelgado
Sep 19, 2014·World Journal of Gastrointestinal Oncology·Ambedkar Raj Kulandai VeluIlavarasi Sinduja

❮ Previous
Next ❯

Citations

Oct 20, 2015·Seminars in Oncology·Edward B Garon
Aug 20, 2015·Journal for Immunotherapy of Cancer·Leila KhojaAnthony M Joshua
Apr 27, 2016·Melanoma Research·Xizhi WenXiao-Shi Zhang
May 11, 2016·Current Opinion in Oncology·Jean A Klastersky
Jun 29, 2016·Immunotherapy·Hampig Raphael Kourie, Jean Klastersky
Mar 31, 2017·The European Respiratory Journal·Charlotte LeducElisabeth Quoix
Jul 6, 2019·The Journal of Clinical Endocrinology and Metabolism·Benedito A CarneiroFrancis J Giles
Jan 17, 2020·CA: a Cancer Journal for Clinicians·Lucy Boyce Kennedy, April K S Salama
Jan 24, 2020·Journal of Cellular Physiology·Ghasem Rahimi Kalateh Shah MohammadSeyed Isaac Hashemy
May 19, 2020·The Western Journal of Emergency Medicine·Brit LongAlex Koyfman
Mar 1, 2016·Clinical and Translational Science·K M MorrisseyS Kasichayanula
Apr 7, 2018·Therapeutic Advances in Medical Oncology·Aaron SosaRafael Rosell
Nov 1, 2015·Melanoma Management·Lavinia SpainJames Larkin
Apr 26, 2017·Nature Reviews. Clinical Oncology·Paul Lorigan, Adele C Green
Sep 14, 2019·American Journal of Respiratory and Critical Care Medicine·Catherine R SearsM Patricia Rivera
Feb 23, 2020·Asia-Pacific Journal of Clinical Oncology·Bei TanJiaming Qian
Sep 5, 2018·Journal for Immunotherapy of Cancer·Guacimara Ortega SanchezHeinz Läubli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.